Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers
Author(s) -
Lori A. Gordon,
Parag Kumar,
Kristina M. Brooks,
Anela Kellogg,
Maryellen McManus,
Raul M. Alfaro,
Khanh Nghiem,
Jomy George,
Jay N. Lozier,
Scott Penzak,
Colleen Hadigan
Publication year - 2016
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.025257
Subject(s) - medicine , pharmacy , cobicistat , clinical pharmacy , dabigatran , human immunodeficiency virus (hiv) , family medicine , warfarin , antiretroviral therapy , viral load , atrial fibrillation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom